Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
62,036,250
-
Total 13F shares
-
47,871,754
-
Share change
-
+1,821,383
-
Total reported value
-
$5,391,239,456
-
Put/Call ratio
-
30%
-
Price per share
-
$112.61
-
Number of holders
-
143
-
Value change
-
+$191,350,357
-
Number of buys
-
65
-
Number of sells
-
80
Institutional Holders of Ascendis Pharma A/S - American Depositary Shares (ASND) as of Q1 2020
As of 31 Mar 2020,
Ascendis Pharma A/S - American Depositary Shares (ASND) was held by
143 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
47,871,754 shares.
The largest 10 holders included
PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, L.P., FMR LLC, BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, Artisan Partners Limited Partnership, Vivo Capital, LLC, JANUS HENDERSON GROUP PLC, Avoro Capital Advisors LLC, and EVENTIDE ASSET MANAGEMENT, LLC.
This page lists
143
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.